Tevogen Bio Holdings Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| – | – | – | – | – | |
| – | +2,361.6% | +63.9% | +6.7% | +26.2% | |
| – | +686.2% | -100.0% | – | -60.2% | |
| – | – | – | -101.9% | – | |
| – | +336.6% | -72.2% | -100.0% | – | |
| – | +336.6% | -72.2% | – | – | |
| – | – | – | – | – | |
| – | -100.0% | – | -75.0% | +240.0% | |
| – | -40.0% | -48.4% | +215.8% | -4.6% | |
| – | -123.0% | – | – | -416.8% | |
| – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.